Blockbuster buzz: 15 top therapies in late-stage development

Blockbuster buzz: 15 top therapies in late-stage development

Submitted by admin on October 11, 2012 - 10:39am
Source: 
Fierce Biotech
News Tags: 
vortioxetine
Vectura
tofacitinib
Takeda
T-DM1
Sanofi
Roche
REGN727
Regeneron
Reata
QVA149
Pfizer
Odanacatib
Novartis
MorphoSys
Merck
macitentan
Lundbeck
Immunogen
GSK
GS-7977
Gilead
gantenerumab
Eliquis
darapladib
Bristol-Myers Squibb
Biogen Idec
BG-12
Bayer
Bardoxolone
Anacetrapib
Alpharadin
Algeta
Actelion
AbbVie
Headline: 
Blockbuster buzz: 15 top therapies in late-stage development

Do Not Allow Advertisers to Use My Personal information